A Phase 1b Study of AMG 757 in Subjects with Neuroendocrine Prostate Cancer
20200040
Phase 1 other active
Quick answer
A Phase 1b Study of AMG 757 in Subjects with Neuroendocrine Prostate Cancer for Adult subjects with de novo or treatment-emergent neuroendocrine prostate cancer is a Phase 1 program (other) at Amgen Technology (Ireland) UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amgen Technology (Ireland) UC
- Indication
- Adult subjects with de novo or treatment-emergent neuroendocrine prostate cancer
- Phase
- Phase 1
- Modality
- other
- Status
- active